Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A for comfort and burden of care in severe cerebral palsy
ACTRN12609000360213Phase 4Recruiting
- Sponsor
- Queensland Paediatric Rehabilitation Service
- Start
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of botulinum toxin type A in cerebral palsy (CP) (2 arms), sponsored by Queensland Paediatric Rehabilitation Service. Primary endpoints: Burden of care and Goal-related satisfaction and performance. Started Mar 2009; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on ACTRN12609000360213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000360213.